explore -WSS

explore

author：entertainment 2025-09-30 12:18:27 - browse：38

Priscilla Chan, left, with Shana Kelley and Gov. J.B. Pritzker of Illinois at the new CZ Biohub Chicago. Courtesy Dale Ramos/Chan Zuckerberg Initiative

CHICAGO — At what point does inflammation, a key component of the body’s immune defense system, swerve out of control and start to drive disease?

That’s the key question that a new research center, the Chan Zuckerberg Biohub Chicago, has been created to try to answer.

The Chicago hub is the second one started by the Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife, Priscilla Chan. The first hub, based in the Bay Area, has been investigating cell biology and infectious diseases, while this new one is homing in on inflammatory processes in tissues across the body.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Type 2 diabetes prevention programs work at large scale: study

WSS

ACIP vaccine advisory panel sees its vacancies filled

Study gives hint on South Asians’ higher risk of cardiovascular disease

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Congress must protect the remaining independent doctors

After decades in use, heart stents finally beat placebo

Here’s what’s in the FDA plan to include pregnant women in clinical trials

focus

explore

explore

Continuity nursing helped my family in our darkest PICU moments

Publishing genetic code of viruses could cause disaster

Drug repurposing or repositioning? The language matters

Why Eli Lilly’s earnings didn’t quite live up to the hype

Cancer drug shortages should be causing more outrage

What is STAT's opinion section for?

Sports medicine is finally prioritizing gender equality

Study suggests Covid rebound is far more common with Paxlovid than without

BioMarin wins approval for gene therapy to treat hemophilia A

Juul documents reveal insider tactics on political lobbying

knowledge

Ventyx halts psoriasis drug development after lackluster trial results

Study gives hint on South Asians’ higher risk of cardiovascular disease

A letter from the executive editor: STAT UnitedHealth investigation

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

White House drug czar issues call for 'recovery

Here’s what’s in the FDA plan to include pregnant women in clinical trials

focus

entertainment

knowledge

focus